
An antiviral drug, Paxlovid, used for treating severe symptoms of COVID-19 is linked with virologic rebound, a new study has found.
COVID rebound is a condition wherein after initial recovery and negative test, a patient either tests positive again, sheds live, potentially contagious virus or experiences the symptoms.